Informa Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India. This move aligns with Mubadala's strategy to generate sustainable financial returns. They have made significant investments globally and are now looking to expand their presence in India's healthcare landscape.

Fortress is expected to benefit from Mubadala Capital’s global network and extensive portfolio of diversified assets

Leading Abu Dhabi investor Mubadala has maintained a strategic push into growth sectors in FY 2022, deploying AED107 billion ($29.1 billion) into industries shaping the future, including the life sciences, renewable energy and digital infrastructure.

Abu Dhabi sovereign investor Mubadala has announced that despite

Assets under management across Mubadala remained above Dhs1tn in 2022